- Home
- SRRK vs AMED Comparison
SRRK vs AMED Comparison
Compare SRRK & AMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- AMED
- Stock Information
- Founded
- SRRK 2012
- AMED 1982
- Country
- SRRK United States
- AMED United States
- Employees
- SRRK N/A
- AMED N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- AMED Medical/Nursing Services
- Sector
- SRRK Health Care
- AMED Health Care
- Exchange
- SRRK Nasdaq
- AMED Nasdaq
- Market Cap
- SRRK 3.1B
- AMED 3.0B
- IPO Year
- SRRK 2018
- AMED N/A
- Fundamental
- Price
- SRRK $30.67
- AMED $95.31
- Analyst Decision
- SRRK Strong Buy
- AMED Hold
- Analyst Count
- SRRK 6
- AMED 6
- Target Price
- SRRK $42.17
- AMED $100.80
- AVG Volume (30 Days)
- SRRK 1.3M
- AMED 409.8K
- Earning Date
- SRRK 05-14-2025
- AMED 04-23-2025
- Dividend Yield
- SRRK N/A
- AMED N/A
- EPS Growth
- SRRK N/A
- AMED N/A
- EPS
- SRRK N/A
- AMED 2.72
- Revenue
- SRRK N/A
- AMED $2,371,691,000.00
- Revenue This Year
- SRRK N/A
- AMED $6.46
- Revenue Next Year
- SRRK $601.05
- AMED $5.00
- P/E Ratio
- SRRK N/A
- AMED $35.06
- Revenue Growth
- SRRK N/A
- AMED 5.34
- 52 Week Low
- SRRK $6.76
- AMED $82.15
- 52 Week High
- SRRK $46.98
- AMED $98.95
- Technical
- Relative Strength Index (RSI)
- SRRK 47.15
- AMED 64.36
- Support Level
- SRRK $28.76
- AMED $95.13
- Resistance Level
- SRRK $33.48
- AMED $96.92
- Average True Range (ATR)
- SRRK 1.71
- AMED 0.95
- MACD
- SRRK -0.04
- AMED 0.12
- Stochastic Oscillator
- SRRK 32.60
- AMED 70.19
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.